IL6 and systemic sclerosis: These results suggest that the NE-induced IL-6/IL-6R trans-signaling might enhance skin fibrosis in SSc, and ARβ inhibitor, propranolol, the p38 inhibitor, SB203580 and STAT3 inhibitor, S31-201 may suppress NE-induced skin fibrosis.